Allen Lutz
Stock Analyst at Bank of America Securities
(4.79)
# 524
Out of 4,534 analysts
578
Total ratings
67.7%
Success rate
13%
Average return
Main Sectors:
Stocks Rated by Allen Lutz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintained: Buy | $70 | $45.22 | +54.80% | 32 | Jul 13, 2026 | |
| WAY Waystar Holding | Maintained: Buy | $38 | $22.09 | +72.02% | 22 | Jul 13, 2026 | |
| HQY HealthEquity | Maintained: Buy | $125 | $98.88 | +26.42% | 56 | Jul 9, 2026 | |
| HIMS Hims & Hers Health | Reiterated: Hold | $36 → $37 | $32.70 | +13.15% | 72 | Jul 8, 2026 | |
| TDOC Teladoc Health | Maintained: Buy | $9 → $11 | $9.65 | +8.81% | 77 | Jul 7, 2026 | |
| COR Cencora | Maintained: Hold | n/a | $303.99 | - | 22 | Jul 2, 2026 | |
| CAH Cardinal Health | Maintained: Buy | $240 → $260 | $225.75 | +15.17% | 20 | Jul 2, 2026 | |
| CVS CVS Health | Maintained: Buy | $110 | $107.61 | +2.22% | 32 | Jul 2, 2026 | |
| MCK McKesson | Maintained: Buy | $900 | $831.46 | +8.24% | 35 | Jul 2, 2026 | |
| GRDN Guardian Pharmacy Services | Maintained: Buy | n/a | $39.78 | - | 5 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $38 → $20 | $21.73 | -7.96% | 42 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $3.5 → $0.7 | $0.7204 | -2.83% | 13 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 | $13.46 | +26.30% | 23 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $31.77 | -2.42% | 22 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $86.20 | - | 22 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 | $26.58 | +27.92% | 21 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.25 | $3.32 | -32.23% | 16 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.6 → $1.9 | $3.14 | -39.49% | 30 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.58 | n/a | 11 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 | $5.64 | n/a | 3 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 → $41 | $0.0001 | n/a | 2 | Aug 10, 2022 |
Omnicell
Jul 13, 2026
Maintained: Buy
Price Target: $70
Current: $45.22
Upside: +54.80%
Waystar Holding
Jul 13, 2026
Maintained: Buy
Price Target: $38
Current: $22.09
Upside: +72.02%
HealthEquity
Jul 9, 2026
Maintained: Buy
Price Target: $125
Current: $98.88
Upside: +26.42%
Hims & Hers Health
Jul 8, 2026
Reiterated: Hold
Price Target: $36 → $37
Current: $32.70
Upside: +13.15%
Teladoc Health
Jul 7, 2026
Maintained: Buy
Price Target: $9 → $11
Current: $9.65
Upside: +8.81%
Cencora
Jul 2, 2026
Maintained: Hold
Price Target: n/a
Current: $303.99
Upside: -
Cardinal Health
Jul 2, 2026
Maintained: Buy
Price Target: $240 → $260
Current: $225.75
Upside: +15.17%
CVS Health
Jul 2, 2026
Maintained: Buy
Price Target: $110
Current: $107.61
Upside: +2.22%
McKesson
Jul 2, 2026
Maintained: Buy
Price Target: $900
Current: $831.46
Upside: +8.24%
Guardian Pharmacy Services
Jul 2, 2026
Maintained: Buy
Price Target: n/a
Current: $39.78
Upside: -
Jun 29, 2026
Downgraded: Sell
Price Target: $38 → $20
Current: $21.73
Upside: -7.96%
Jun 29, 2026
Downgraded: Sell
Price Target: $3.5 → $0.7
Current: $0.7204
Upside: -2.83%
Jun 11, 2026
Maintained: Buy
Price Target: $17
Current: $13.46
Upside: +26.30%
Jun 2, 2026
Reiterated: Buy
Price Target: $31
Current: $31.77
Upside: -2.42%
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $86.20
Upside: -
May 14, 2026
Maintained: Buy
Price Target: $34
Current: $26.58
Upside: +27.92%
Mar 31, 2026
Reiterated: Sell
Price Target: $2.25
Current: $3.32
Upside: -32.23%
Feb 26, 2026
Reiterated: Sell
Price Target: $2.6 → $1.9
Current: $3.14
Upside: -39.49%
Aug 5, 2024
Rated: Hold
Price Target: n/a
Current: $12.58
Upside: n/a
Jun 20, 2023
Maintained: Hold
Price Target: $12
Current: $5.64
Upside: n/a
Aug 10, 2022
Maintained: Hold
Price Target: $50 → $41
Current: $0.0001
Upside: n/a